Literature DB >> 16985626

Advances in the Medical Treatment of Prostate Cancer, Bladder Cancer, Renal Cell Cancer, and Benign Prostatic Hyperplasia: Highlights from the XVIIth Congress of the European Association of Urology, Birmingham, UK, February 23-26, 2002.

Christian Seitz, Mesut Remzi, Bob Djavan, Claus G Roehrborn.   

Abstract

Entities:  

Year:  2003        PMID： 16985626      PMCID： PMC1473008     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  9 in total

1.  Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer.

Authors:  A V D'Amico; R Whittington; S B Malkowicz; J Fondurulia; M H Chen; I Kaplan; C J Beard; J E Tomaszewski; A A Renshaw; A Wein; C N Coleman
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

2.  Effect of laparoscopic pelvic lymph node dissection on the natural history of D1 (T1-3, N1-3, M0) prostate cancer.

Authors:  J A Cadeddu; O M Elashry; O Snyder; P Schulam; R G Moore; K R Loughlin; H N Winfield; R V Clayman; L R Kavoussi
Journal:  Urology       Date:  1997-09       Impact factor: 2.649

3.  Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: a prospective randomized study.

Authors:  T Granfors; H Modig; J E Damber; R Tomic
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

4.  Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.

Authors:  E M Messing; J Manola; M Sarosdy; G Wilding; E D Crawford; D Trump
Journal:  N Engl J Med       Date:  1999-12-09       Impact factor: 91.245

5.  Improved prognostication of renal cell carcinoma using an integrated staging system.

Authors:  A Zisman; A J Pantuck; F Dorey; J W Said; O Shvarts; D Quintana; B J Gitlitz; J B deKernion; R A Figlin; A S Belldegrun
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

6.  A catalog of prostate cancer nomograms.

Authors:  P L Ross; P T Scardino; M W Kattan
Journal:  J Urol       Date:  2001-05       Impact factor: 7.450

7.  Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer.

Authors:  R Jüri Palisaar; Markus Graefen; Pierre I Karakiewicz; Peter G Hammerer; Edith Huland; Alexander Haese; Salvator Fernandez; Andreas Erbersdobler; Rolf-Peter Henke; Hartwig Huland
Journal:  Eur Urol       Date:  2002-02       Impact factor: 20.096

8.  Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.

Authors:  Frans Debruyne; Gary Koch; Peter Boyle; Fernando Calais Da Silva; Jay G Gillenwater; Freddie C Hamdy; Paul Perrin; Pierre Teillac; Remigio Vela-Navarrete; Jean-Pierre Raynaud
Journal:  Eur Urol       Date:  2002-05       Impact factor: 20.096

9.  Alternating mitomycin C and BCG instillations versus BCG alone in treatment of carcinoma in situ of the urinary bladder: a nordic study.

Authors:  Eero Kaasinen; Hans Wijkström; Per Uno Malmström; Sverker Hellsten; Milos Duchek; Oddvar Mestad; Erkki Rintala
Journal:  Eur Urol       Date:  2003-06       Impact factor: 20.096
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.